Inhibition of the intrinsic coagulation pathway factor XI by antisense oligonucleotides: a novel antithrombotic strategy with lowered bleeding risk

RNA Targeting Therapeutics: Molecular Mechanisms of Antisense Oligonucleotides as a Therapeutic Platform

(2010) C. Frank Bennett et al.   Annual Review of Pharmacology and Toxicology

Platelet Polyphosphates Are Proinflammatory and Procoagulant Mediators In Vivo

(2009) Felicitas Müller et al.   CELL

Comparative Metabolism of 14C-Labeled Apixaban in Mice, Rats, Rabbits, Dogs, and Humans

(2009) D. Zhang et al.   DRUG METABOLISM AND DISPOSITION

Favorable therapeutic index of the direct factor Xa inhibitors, apixaban and rivaroxaban, compared with the thrombin inhibitor dabigatran in rabbits

(2009) P. C. WONG et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Factor VII Deficiency

(2009) Guglielmo Mariani et al.   SEMINARS IN THROMBOSIS AND HEMOSTASIS

Prevention of vascular graft occlusion and thrombus-associated thrombin generation by inhibition of factor XI

(2008) E. I. Tucker et al.   BLOOD

Genetic elimination of prothrombin in adult mice is not compatible with survival and results in spontaneous hemorrhagic events in both heart and brain

(2008) E. S. Mullins et al.   BLOOD

Reduced incidence of ischemic stroke in patients with severe factor XI deficiency

(2008) O. Salomon et al.   BLOOD

New anticoagulants

(2008) Kenneth A Bauer   CURRENT OPINION IN HEMATOLOGY

Survival of Heparins, Oral Anticoagulants, and Aspirin after the Year 2010

(2008) Jawed Fareed et al.   SEMINARS IN THROMBOSIS AND HEMOSTASIS